US Urges Justices Not To Review Drug Exec's $1M Tax Penalty
By David Hansen · May 16, 2023, 6:35 PM EDT
The U.S. Supreme Court should not accept a drug company executive's challenge to lower courts' findings that there is an objective standard for his reckless failure to report foreign bank accounts,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login